Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders

Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are recognized as a significant complication in this pat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bone Marrow Transplant
Autori principali: Gupta, Ashish O., Jan Boelens, Jaap, Ebens, Christen L., Kurtzberg, Joanne, Lund, Troy C., Smith, Angela R., Wagner, John E., Wynn, Robert, Blazar, Bruce R., Orchard, Paul J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Perspective
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189901/
https://ncbi.nlm.nih.gov/pubmed/33441980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01179-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi